HMGB1-Directed Drug Discovery Targeting Cutaneous Inflammatory Dysregulation

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|11|3|250-265

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.11, Iss.3, 2010-03, pp. : 250-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review: Therapeutic Targeting of HMGB1 in Stroke

By  

Current Drug Delivery, Vol. 14, Iss. 6, 2017-09 ,pp. : 785-790

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting enzyme inhibitors in drug discovery

By Copeland Robert A   Harpel Mark R   Tummino Peter J  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 967-978

Informa Healthcare

Access to resources Recommend Favorite

Drug Discovery and Development for Inflammatory Diseases

By Edwards III Carl K  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 2, 2004-04 ,pp. : 151-163

Informa Healthcare

Access to resources Recommend Favorite

New directions in drug discovery: targeting RNA

By  

Inpharma, Vol. 1, Iss. 1386, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Antiviral Drug Discovery Targeting to Viral Proteases

By  

Current Pharmaceutical Design, Vol. 12, Iss. 11, 2006-04 ,pp. : 1301-1314

Bentham Science Publishers

Access to resources Recommend Favorite